Forkhead transcription factor Foxa1 is a novel target gene of C/EBPβ and suppresses the early phase of adipogenesis

Gene

Volumn 473, Issue 2, 2011, Pages 150-156

  Fujimori, Ko ^a   Amano, Fumio ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Adipocytes; C EBP ; Foxa1; Promoter; Suppression

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; MICE; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING;

EID: 79551686255     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.12.002     Document Type: Article

References (28)

1. Ang S.L., Rossant J. HNF-3 beta is essential for node and notochord formation in mouse development. Cell 1994, 78:561-574.
2. Bergman R.N., et al. Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 2001, 49:119-126.
3. Cartharius K., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
4. Cederberg A., Gronning L.M., Ahren B., Tasken K., Carlsson P., Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 2001, 106:563-573.
5. Davis K.E., Moldes M., Farmer S.R. The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J. Biol. Chem. 2004, 279:42453-42461.
6. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4:263-273.
7. Fujimori K., Fujitani Y., Kadoyama K., Kumanogoh H., Ishikawa K., Urade Y. Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells. J. Biol. Chem. 2003, 278:6018-6026.
8. Fujimori K., Kadoyama K., Urade Y. Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of Notch-Hes signaling and enhancement of AP-2 beta function in brain-derived TE671 cells. J. Biol. Chem. 2005, 280:18452-18461.
9. Fujimori K., Aritake K., Urade Y. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J. Biol. Chem. 2007, 282:18458-18466.
10. Fujimori K., et al. Suppression of Adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J. Biol. Chem. 2010, 285:8880-8886.
11. Gerin I., Bommer G.T., Lidell M.E., Cederberg A., Enerback S., Macdougald O.A. On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. J. Biol. Chem. 2009, 284:10755-10763.
12. Hannenhalli S., Kaestner K.H. The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 2009, 10:233-240.
13. Kaestner K.H. The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol. Metab. 2000, 11:281-285.
14. Kaestner K.H., Hiemisch H., Schutz G. Targeted disruption of the gene encoding hepatocyte nuclear factor 3gamma results in reduced transcription of hepatocyte-specific genes. Mol. Cell. Biol. 1998, 18:4245-4251.
15. Kaestner K.H., Katz J., Liu Y., Drucker D.J., Schutz G. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 1999, 13:495-504.
16. Kim J.K., et al. Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance. Diabetes 2005, 54:1657-1663.
17. Lantz K.A., Kaestner K.H. Winged-helix transcription factors and pancreatic development. Clin. Sci. (Lond) 2005, 108:195-204.
18. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20:107-114.
19. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580:2917-2921.
20. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2004, 24:29-33.
21. Morrison R.F., Farmer S.R. Hormonal signaling and transcriptional control of adipocyte differentiation. J. Nutr. 2000, 130:3116S-3121S.
22. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 2003, 4:119-129.
23. Sharma A.M., Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 2007, 92:386-395.
24. Shih D.Q., Navas M.A., Kuwajima S., Duncan S.A., Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10152-10157.
25. Shih D.Q., Heimesaat M., Kuwajima S., Stein R., Wright C.V., Stoffel M. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3818-3823.
26. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
27. Weinstein D.C., et al. The winged-helix transcription factor HNF-3 beta is required for notochord development in the mouse embryo. Cell 1994, 78:575-588.
28. Wolfrum C., Shih D.Q., Kuwajima S., Norris A.W., Kahn C.R., Stoffel M. Role of Foxa-2 in adipocyte metabolism and differentiation. J. Clin. Invest. 2003, 112:345-356.